Helping you developbiologics faster and easierfor patients in need
Deep knowledge ofpre-clinical technologiesand methods
Experts in antigen design and hybridoma development.
In-depth experience from gene synthesis and subcloning to protein expression and purification.
Proven track record for a broad range of in vitro and in vivo models of disease.
Short timelines and high titers at every development stage with CLD services.
Relive our June 20th webinar! Instant Replay
Stay tuned for our next conference!
Download our new capabilities brochure!
…a solid performer for my company’s animal studies…
Elisabeth Gardiner, PhD Chief Scientific Officer Meditope Biosciences, Inc.
GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.
Aragen Bioscience Expands Cell Line Development Services
Aragen Bioscience Announces AAALAC Accreditation